Creating a clinical trials community: 3 questions every trialist should ask themselves

Abstract

The COVID-19 pandemic has presented an opportunity to transform what has been historically termed “human subjects” in clinical research. This editorial advocates patient involvement in all phases of co-developing clinical research design and suggests every clinical trialist ask themselves three key questions before starting their next research project.